Dawson NA - Search Results

1

Platinum-free combination chemotherapy in patients with advanced or metastatic transitional cell carcinoma.

Lara PN Jr, Meyers FJ, Law LY, Dawson NA, Houston J, Lauder I, Edelman MJ. Lara PN Jr, et al. Among authors: dawson na. Cancer. 2004 Jan 1;100(1):82-8. doi: 10.1002/cncr.11866. Cancer. 2004. PMID: 14692027 Free article. Clinical Trial.

2

Clinical predictors of response in metastatic germ cell tumors.

Taylor G, Perry DJ, Knight RD, Dawson NA, Skoog SJ, McLeod DG. Taylor G, et al. Among authors: dawson na. Cancer. 1988 Jul 1;62(1):217-21. doi: 10.1002/1097-0142(19880701)62:1<217::aid-cncr2820620133>3.0.co;2-l. Cancer. 1988. PMID: 2454719

3

A randomized study comparing standard versus moderately high dose megestrol acetate for patients with advanced prostate carcinoma: cancer and leukemia group B study 9181.

Dawson NA, Conaway M, Halabi S, Winer EP, Small EJ, Lake D, Vogelzang NJ. Dawson NA, et al. Cancer. 2000 Feb 15;88(4):825-34. Cancer. 2000. PMID: 10679652 Clinical Trial.

4

A phase I study of the somatostatin analogue somatuline in patients with metastatic hormone-refractory prostate cancer.

Figg WD, Thibault A, Cooper MR, Reid R, Headlee D, Dawson N, Kohler DR, Reed E, Sartor O. Figg WD, et al. Cancer. 1995 Apr 15;75(8):2159-64. doi: 10.1002/1097-0142(19950415)75:8<2159::aid-cncr2820750820>3.0.co;2-o. Cancer. 1995. PMID: 7535186 Clinical Trial.

5

Salvage therapy in metastatic adult Wilms' tumor.

Dawson NA, Klein MA, Taylor HG. Dawson NA, et al. Cancer. 1988 Sep 1;62(5):1017-21. doi: 10.1002/1097-0142(19880901)62:5<1017::aid-cncr2820620530>3.0.co;2-i. Cancer. 1988. PMID: 2842024

6

A pilot trial of chemohormonal therapy for metastatic prostate carcinoma.

Dawson NA, Wilding G, Weiss RB, McLeod DG, Linehan WM, Frank JA, Jacob JL, Gelmann EP. Dawson NA, et al. Cancer. 1992 Jan 1;69(1):213-8. doi: 10.1002/1097-0142(19920101)69:1<213::aid-cncr2820690135>3.0.co;2-v. Cancer. 1992. PMID: 1727665 Clinical Trial.

7

Chemotherapy of disseminated Merkel-cell carcinoma.

Redmond J 3rd, Perry J, Sowray P, Vukelja SJ, Dawson N. Redmond J 3rd, et al. Am J Clin Oncol. 1991 Aug;14(4):305-7. doi: 10.1097/00000421-199108000-00006. Am J Clin Oncol. 1991. PMID: 1862761

8

A Phase II Clinical Trial of TRC105 (Anti-Endoglin Antibody) in Adults With Advanced/Metastatic Urothelial Carcinoma.

Apolo AB, Karzai FH, Trepel JB, Alarcon S, Lee S, Lee MJ, Tomita Y, Cao L, Yu Y, Merino MJ, Madan RA, Parnes HL, Steinberg SM, Rodriguez BW, Seon BK, Gulley JL, Arlen PM, Dawson NA, Figg WD, Dahut WL. Apolo AB, et al. Among authors: dawson na. Clin Genitourin Cancer. 2017 Feb;15(1):77-85. doi: 10.1016/j.clgc.2016.05.010. Epub 2016 May 27. Clin Genitourin Cancer. 2017. PMID: 27328856 Free PMC article. Clinical Trial.

9

A phase II trial of gefitinib (Iressa, ZD1839) in stage IV and recurrent renal cell carcinoma.

Dawson NA, Guo C, Zak R, Dorsey B, Smoot J, Wong J, Hussain A. Dawson NA, et al. Clin Cancer Res. 2004 Dec 1;10(23):7812-9. doi: 10.1158/1078-0432.CCR-04-0310. Clin Cancer Res. 2004. PMID: 15585612 Clinical Trial.

10

A phase I/II study of continuous infusion suramin in patients with hormone-refractory prostate cancer: toxicity and response.

Bowden CJ, Figg WD, Dawson NA, Sartor O, Bitton RJ, Weinberger MS, Headlee D, Reed E, Myers CE, Cooper MR. Bowden CJ, et al. Among authors: dawson na. Cancer Chemother Pharmacol. 1996;39(1-2):1-8. doi: 10.1007/s002800050531. Cancer Chemother Pharmacol. 1996. PMID: 8995493 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

126 results

Search Page

Filters